← Back to patent-cliff list
SR-750
Tier C — Watch / tradeSR-750
Australia
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Ion channels
Indications (approved)：三叉神经痛, 神经痛, Peripheral nervous system disorder
Regional status
US
-
EU
-
China
Phase II
2024-09-16
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of SR-750?
Approved indications include: 三叉神经痛, 神经痛, Peripheral nervous system disorder.
When does the SR-750 patent expire?
No public expiry year is available for SR-750 yet; this page updates once verified.
How do I get a quote for SR-750 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01